Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in japanese patients with hepatocellular carcinoma

Oncology (Switzerland)

Volumn 54, Issue 4, 1997, Pages 304-310

  Kishimoto, Yosuke ^a   Shiom, Goshi ^b   Kamisaki, Yoshinori ^a   Wada, Kouichirou ^a   Nakamoto, Kentaro ^a   Yamawaki, Masahiro ^a   Kotani, Masahiro ^a   Itoh, Tadao ^a   Kawasaki, Hironaka ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Loss of heterozygosity; p53

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; FEMALE; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE DELETION; GENES, P53; HETEROZYGOTE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0030905316     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227708     Document Type: Article

References (60)

1. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Ann Surg 1990:21: 277-287.
2. Roger CE, Chisari FV: Cellular and molecular mechanism of hcpatocarcinogcnesis. Semin Liver Dis 1992:12:265-278.
3. Marx J: How p53 suppresses cell growth. Science 1993;262:1644-1645.
4. Perry ME, Levine AJ: Tumor suppressor gene p53 and the cell cycle. Curr Opin Genet Dev 1993:3:50-54.
5. Murakami Y, Hayashi K, Hirohashi S, Sckiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991;51:5520-5525.
6. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishika-wa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y: Allclotypc study of primary hepatocellular carcinoma. Cancer Res 1991:51:89-93.
7. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura M, Ishizaki K: Accumulation of allele loss on arms of chromosomes 13q, I6qand 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 1992;52:862-868.
8. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DY, Ikenaga M, Hiroo I, Ishizaki K: Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993:53:368-372.
9. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-428.
10. Bressac B, Kew M, Wands J, Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-431.
11. Tcramoto T, Salonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S: p53 gene abnormalities arc closely related to hcpatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994;54:231-235.
12. Crook T, Tidy JA, Vousden KH: Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991;67:547-556.
13. Hubbert NL, Sedman SA, Schiller JT: Human papillomavirus type 16 E6 increases the degradation rate of p53 in human kératinocytes. J Virol 1992;66:6237-6241.
14. Yew PR, Berk AJ: Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 1992:357:82-85.
15. Wakabayashi K, Nagao M, Esumi H, Sugimura T: Food-derived mutagens and carcinogens. Cancer Res 1992:52:2092s-2098s.
16. Harris CC: Chemical and physical carcinogenesis: Advances and prospectives for the 1990s. Cancer Res 1991:51:5023s-5044s.
17. Montand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 1992:69:1237-1245.
18. Hainaut P, Milner J: Interaction ofheat-shock protein 70 with p53 translated in vitro: Evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBOJ 1992:11:3513-3520.
19. Livm N, Eid A, Han Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E: p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 1995;75:2420-2426.
20. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531-539.
21. Marshall CJ: Tumor suppressor genes. Cell 1991:64:313-326.
22. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW: p53 gene mutations and protein accumulation in human ovarian cancer. Proc Nall Acad Sci USA 1993:90:4961-4965.
23. Cesarman E, Inghiram G, Chadbum A, Knowles DM: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 1993;3:845-856.
24. Rubio MP, Deimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN: Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 1993:53:3465-3467.
25. Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW: High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic. low grade and anaplastic astrocytomas. Oncogene 1994:9:949-954.
26. Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B: p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 1995; 108:1176-1182.
27. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology 1992:15:948-963.
28. Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF: K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994:54:5811-5815.
29. Kishimoto Y, Sugio K, Hung JY, Virmani AK, Mclntire DD, Minna JD, Gazdar AF: Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 1995:87:1224-1229.
30. Jones MH, Nakamura Y: Detection of loss of heterozygosity at the human TP53 locus using a dinuclcotide repeat polymorphism. Genes Chromosom Cancer 1992:5:89-90.
31. Futreal PA, Barrett JC, Wiseman RW: An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 1991;19:6977.
32. Pââbo S: Ancient DNA: Extraction, characterization, molecular cloning, and enzymatic amplification. Proc Natl Acad Sci USA 1989:86: 1939-1943.
33. Lerer I, Meiner V, Pashut-Lavon I, Abeliovich D: Molecular diagnosis of Prader-Willi syndrome: Parcnt-of-origin dependent méthylation sites and nonisotopic detection of (CA)n dinuclcotide repeat polymorphisms. Am J Med Genet 1994:52:79-84.
34. Wang HP, Rogler CE: Deletions in human chromosome arms lip and 13q in primary' hepatocellular carcinomas. Cytogenet Cell Genet 1988:48:72-78.
35. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Rcdeker A, Govindarajah S: Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad SciUSA 1988:86:8852-8856.
36. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hiroha-shi S: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990:87: 6791-6794.
37. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T: Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 1990;81:108-111.
38. Ding S-F, Habib NA, Dooley J, Wood C, Bowles L, Delhanty JDA: Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 1991:64:1083-1087.
39. Simon D, Knowles BB, Wcith A: Abnormalities of chromosome 1 and loss of heterozygosity on lp in primary hepatomas. Oncogene 1991: 6:765-770.
40. Walker GJ, Hayward NK, Falvey S, Cooksley WGE: Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 1991:51: 4367-4370.
41. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res 1992;52:5368-5372.
42. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y: Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 1993;17:794-799.
43. Oren M: p53: The ultimate suppressor gene? FASEBJ 1992:6:3169-3176.
44. Feitclson MA, Zhu M, Duan L-X, London WT: Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109-1117.
45. Hsia CC, Kleiner DE, Axiotis CA, Bisccglie AD. Nomura AMY, Stemmermann GN, Tabor E: Mutations of p53 gene in hepatocellular carcinoma: Roles ofhepatitisB virus and aflatoxin contamination in the dieT, J Natl Cancer Inst 1992;84:1638-1641.
46. Puisicux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ozturk M: Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEBJ 1993;7:1407-1413.
47. Hung J, Kishimoto Y, Sugio K, Virmani A, Mclntire DD, Minna JD, Gazdar AF: Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:558-563.
48. Wistuba II, Sugio K, Hung JY, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF: Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995:55:2511-2515.
49. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM. Bos JL: Genetic altcr-ationsduringcolorcctal-tumor developmenT, N Engl J Med 1988;319:525-539.
50. Mazats R, Pujol P, Maudelonde T, Jeanteur P, Theillet C: p53 mutations in ovarian cancer: A late event? Oncogene 1991;6:1685-1690.
51. Ito T, Scyama T, Mizuno T, Tsuyama N, Haya-shi T, Hayashi Y, Dohi K, Nakamura N, Akiyama M: Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 1992;52:1369-1371.
52. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbits P: p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 1992:7:1989-1997.
53. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992:52: 6358-6364.
54. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993:53:2884- 2887.
55. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K: The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 1995:22: 1702-1707.
56. Tominaga O, Hamclin R, Trouvat V, Salmon RJ, Lesec G, Thomas G, Remvikes Y: Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene 1993:8:2653-2658.
57. Shiao Y-H, Rugge M, Correa P, Lehmann HP, Scheer WD: p53 alteration in gastric precancer-ous lesions. Am J Pathol 1994:144:511-517.
58. Esumi M, Aritaka T, Arii M, Suzuki K, Tanika-wa K, Mizuno H, Mima T, Shikala T: Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res 1986:46:5767-5771.
59. Chen P-Jm, Chen D-S, Lai M-Y, Chang M-H, Huang G-T, Yang P-M, Sheu J-C, Lee S-C, Hsu H-C, Sung J-L: Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989; 96:527-529.
60. Sakamoto M, Hirohasi S, Shimosato Y: Early stages of multistep hcpatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178.